TrialClinical rheumatology2022

Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).

Ruediger B Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.